炎症性肠病患者叶酸补充治疗的研究进展
Research Progress in Folic Acid Supplementation Treatment in Patients with Inflammatory Bowel Disease
DOI: 10.12677/ACM.2023.13122673, PDF,   
作者: 白 宇, 王嫣琦, 郭宇扬：西安医学院研究生工作部，陕西 西安 ；刘丹平*：陕西省人民医院急诊内科，陕西 西安
关键词: 炎症性肠病；叶酸缺乏；补充治疗；Inflammatory Bowel Disease； Folic Acid Deficiency； Supplementary Treatment
摘要: 炎症性肠病是一种病因未明的慢性肠道炎性疾病，主要包括溃疡性结肠炎和克罗恩病。炎症性肠病患者营养不良的发生率较高，相关营养治疗研究不胜枚举。叶酸作为人体必需微量营养素之一，在炎症性肠病的治疗中愈发受到重视。国外最新营养指南建议给予叶酸缺乏的患者定期的叶酸水平监测，并提供相应强化补充治疗，但目前有关炎症性肠病患者叶酸综合补充治疗仍有争议。本文章就此病患者中叶酸缺乏情况及补充治疗等方面进行探讨和总结，为临床诊疗提供参考价值。
Abstract: Inflammatory bowel disease is a chronic intestinal inflammatory disease with an unknown cause, mainly including ulcerative colitis and Crohn’s disease. The incidence of malnutrition in patients with inflammatory bowel disease is relatively high, and the relevant nutritional treatment studies are numerous. Folic acid, as one of the essential micronutrients, is receiving more and more atten-tion in the treatment of inflammatory bowel disease. The latest foreign nutrition guidelines rec-ommend regular folic acid level monitoring for patients with folic acid deficiency and provide cor-responding intensive supplementary treatment, but there is still controversy about the compre-hensive folic acid supplementation treatment for patients with inflammatory bowel disease. This article discusses and summarizes folic acid deficiency and supplementary treatment in patients with this disease to provide reference value for clinical diagnosis and treatment.
文章引用：白宇, 刘丹平, 王嫣琦, 郭宇扬. 炎症性肠病患者叶酸补充治疗的研究进展[J]. 临床医学进展, 2023, 13(12): 19004-19009. https://doi.org/10.12677/ACM.2023.13122673

参考文献

[1] Xu, L., He, B., Sun, Y., et al. (2023) Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Popula-tion-Based Study. Clinical Gastroenterology and Hepatology, 21, 3379-3386.e29.
[2] Mak, W.Y., Zhao, M., Ng, S.C. and Burisch, J. (2020) The Epidemiology of Inflammatory Bowel Disease: East Meets West. Journal of Gastroenterology and Hepatology, 35, 380-389. [Google Scholar] [CrossRef] [PubMed]
[3] Massironi, S., Viganò, C., Palermo, A., et al. (2023) Inflammation and Malnutrition in Inflammatory Bowel Disease. The Lancet Gastroenterology and Hepatology, 8, 579-590. [Google Scholar] [CrossRef] 
[4] Park, Y.E., Park, S.J., Park, J.J., et al. (2021) Incidence and Risk Factors of Micronutrient Deficiency in Patients with IBD and Intestinal Behçet’s Disease: Folate, Vitamin B12, 25-OH-Vitamin D, and Ferritin. BMC Gastroenterology, 21, Article No. 32. [Google Scholar] [CrossRef] [PubMed]
[5] Casanova, M.J., Chaparro, M., Molina, B., et al. (2017) Preva-lence of Malnutrition and Nutritional Characteristics of Patients with Inflammatory Bowel Disease. Journal of Crohn’s and Colitis, 11, 1430-1439. [Google Scholar] [CrossRef] [PubMed]
[6] Schreiner, P., Martinho-Grueber, M., Studerus, D., et al. (2020) Nutri-tion in Inflammatory Bowel Disease. Digestion, 101, 120-135. [Google Scholar] [CrossRef] [PubMed]
[7] Bermejo, F., Algaba, A., Guerra, I. and Gisbert, J.P. (2014) Response to Letter: Folate Deficiency in Crohn’s Disease. Scandinavian Journal of Gastroenterology, 49, 255-256. [Google Scholar] [CrossRef] [PubMed]
[8] Dignass, A.U., Gasche, C., Bettenworth, D., et al. (2015) European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases. Journal of Crohn’s and Colitis, 9, 211-222. [Google Scholar] [CrossRef] [PubMed]
[9] Shulpekova, Y., Nechaev, V., Kardasheva, S., et al. (2021) The Con-cept of Folic Acid in Health and Disease. Molecules, 26, Article 3731. [Google Scholar] [CrossRef] [PubMed]
[10] Pan, Y., Liu, Y., Guo, H., et al. (2017) Associations between Fo-late and Vitamin B12 Levels and Inflammatory Bowel Disease: A Meta-Analysis. Nutrients, 9, Article 382. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, J., Ruan, X., Yuan, S., et al. (2023) Antioxidants, Minerals and Vitamins in Relation to Crohn’s Disease and Ulcerative Colitis: A Mendelian Randomization Study. Alimentary Phar-macology & Therapeutics, 57, 399-408. [Google Scholar] [CrossRef] [PubMed]
[12] Mölzer, C., Wilson, H.M., Kuffova, L. and Forrester, J.V. (2021) A Role for Folate in Microbiome-Linked Control of Autoimmunity. Journal of Immunology Research, 2021, Article ID: 9998200. [Google Scholar] [CrossRef] [PubMed]
[13] Moein, S., Vaghari-Tabari, M., Qujeq, D., et al. (2020) As-sociation between Serum Folate with Inflammatory Markers, Disease Clinical Activity and Serum Homocysteine in Pa-tients with Inflammatory Bowel Disease. Does Folate Level Have an Effect on Maintaining Clinical Remission? Acta Biomedica, 91, e2020106.
[14] 吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年∙北京) [J]. 中国实用内科杂志, 2018, 38(9): 796-813.
[15] Jeličić, M.L., Brusač, E., Klarić, D.A., et al. (2020) A Chromatograph-ic Approach to Development of 5-Aminosalicy- late/Folic Acid Fixed-Dose Combinations for Treatment of Crohn’s Disease and Ulcerative Colitis. Scientific Reports, 10, Article No. 20838. [Google Scholar] [CrossRef] [PubMed]
[16] Jansen, G., van der Heijden, J., Oerlemans, R., et al. (2004) Sul-fasalazine Is a Potent Inhibitor of the Reduced Folate Carrier: Implications for Combination Therapies with Methotrexate in Rheumatoid Arthritis. Arthritis & Rheumatology, 50, 2130-2139. [Google Scholar] [CrossRef] [PubMed]
[17] Jeličić, M.L., Brusač, E., Kurajica, S., et al. (2021) Drug-Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools. Pharmaceutics, 13, Article 400. [Google Scholar] [CrossRef] [PubMed]
[18] Jiang, R., Mei, S. and Zhao, Z. (2022) Leucovorin (Folinic Acid) Rescue for High-Dose Methotrexate: A Review. Journal of Clinical Pharmacy and Therapeutics, 47, 1452-1460. [Google Scholar] [CrossRef] [PubMed]
[19] Cline, A. and Jorizzo, J.L. (2017) Does Daily Folic Acid Supplementation Reduce Methotrexate Efficacy? Dermatology Online Journal, 23, Article 6. [Google Scholar] [CrossRef] 
[20] Zwart, N., Franken, M.D., Tissing, W., et al. (2023) Folate, Folic Ac-id, and Chemotherapy-Induced Toxicities: A Systematic Literature Review. Critical Reviews in Oncology/Hematology, 188, Article ID: 104061. [Google Scholar] [CrossRef] [PubMed]
[21] 李明松, 石汉平, 杨桦. 中国炎症性肠病饮食管理专家建议[J]. 中华消化病与影像杂志(电子版), 2021, 11(3): 97-105.
[22] Obeid, R., Oexle, K., Rißmann, A., et al. (2016) Folate Status and Health: Challenges and Opportunities. Journal of Perinatal Medicine, 44, 261-268. [Google Scholar] [CrossRef] [PubMed]
[23] 中国医药教育协会临床合理用药专业委员会, 中国医疗保健国际交流促进会高血压分会, 中国妇幼保健协会围产营养与代谢专业委员会, 等. 中国临床合理补充叶酸多学科专家共识[J]. 中国医学前沿杂志(电子版), 2020, 12(11): 19-37.
[24] Wilson, R.D. and O’Connor, D.L. (2022) Guide-line No. 427: Folic Acid and Multivitamin Supplementation for Prevention of Folic Acid-Sensitive Congenital Anomalies. Journal of Obstetrics and Gynaecology Canada, 44, 707-719. [Google Scholar] [CrossRef] [PubMed]
[25] Guagnozzi, D. and Lucendo, A.J. (2014) Anemia in Inflammatory Bowel Disease: A Neglected Issue with Relevant Effects. World Journal of Gastroenterology, 20, 3542-3551. [Google Scholar] [CrossRef] [PubMed]
[26] Faye, A.S., Holmer, A.K. and Axelrad, J.E. (2022) Cancer in In-flammatory Bowel Disease. Gastroenterology Clinics of North America, 51, 649-666. [Google Scholar] [CrossRef] [PubMed]
[27] Biasco, G. and Di Marco, M.C. (2005) Folate and Prevention of Colorectal Cancer in Ulcerative Colitis. European Journal of Cancer Prevention, 14, 395-398. [Google Scholar] [CrossRef] [PubMed]
[28] Lee, J.E., Willett, W.C., Fuchs, C.S., et al. (2011) Folate Intake and Risk of Colorectal Cancer and Adenoma: Modification by Time. The American Journal of Clinical Nutrition, 93, 817-825. [Google Scholar] [CrossRef] [PubMed]
[29] Moazzen, S., Dastgiri, S., Dolatkhah, R., et al. (2020) Folic Acid Supplement Intake and Risk of Colorectal Cancer in Women; A Case Control Study. Annals of Global Health, 86, Article 23. [Google Scholar] [CrossRef] [PubMed]
[30] Fu, H., He, J., Li, C.C., Deng, Z.H. and Chang, H. (2023) Folate Intake and Risk of Colorectal Cancer: A Systematic Review and up-to-Date Meta-Analysis of Prospective Studies. European Journal of Cancer Prevention, 32, 103-112. [Google Scholar] [CrossRef] 
[31] Hanley, M.P. and Rosenberg, D.W. (2015) One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of Chemoprevention. Current Pharmacology Reports, 1, 197-205. [Google Scholar] [CrossRef] [PubMed]
[32] Fardous, A.M., Beydoun, S., James, A.A., et al. (2021) The Timing and Duration of Folate Restriction Differentially Impacts Colon Carcinogenesis. Nutrients, 14, Article 16. [Google Scholar] [CrossRef] [PubMed]
[33] Bezzio, C., Festa, S., Saibeni, S. and Papi, C. (2017) Chemoprevention of Colorectal Cancer in Ulcerative Colitis: Digging Deep in Current Evidence. Expert Review of Gastroenterology & Hepa-tology, 11, 339-347. [Google Scholar] [CrossRef] [PubMed]
[34] Ratajczak, A.E., Szymczak-Tomczak, A., Rychter, A.M., et al. (2021) Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications? Nutrients, 13, Article 4036. [Google Scholar] [CrossRef] [PubMed]
[35] Liang, P.S., Shaukat, A. and Crockett, S.D. (2021) AGA Clinical Practice Update on Chemoprevention for Colorectal Neoplasia: Expert Review. Clinical Gastroenterology and Hepatol-ogy, 19, 1327-1336. [Google Scholar] [CrossRef] [PubMed]

为你推荐